Drug Profile
Research programme: drug discovery - TPP Global Development
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator TPP Global Development; University of Edinburgh
- Class
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer; Immunological disorders; Inflammation; Neurological disorders
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Cancer in United Kingdom
- 16 Jul 2016 No recent reports of development identified for research development in Immunological-disorders in United Kingdom
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in United Kingdom